# A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-comparison-of-all-cause-mortality-with-pioglitazone-and-insulin-in-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jiao Yang,Carlos Vallarino,Morgan Bron,Alfonso Pérez,Huifang Liang,Guiandre Joseph,Shawn Yu |
| Citations | 24 |
| DOI | 10.1185/03007995.2014.941054 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2040699877 |
| PMID | 24983744 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Morgan Bron](https://scholariq.org/researchers/morgan-bron/)

## Paper journal

- [Current Medical Research and Opinion](https://scholariq.org/journals/current-medical-research-and-opinion/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.